Cannabis and chronic pain in Australia – Health Europa

Despite making up around 60% to 70% of the customer base for Australias medical cannabis market, chronic pain patients in Australia still face a variety of barriers to access, ranging from issues around cost to the ongoing reluctance of many doctors to prescribe cannabis as a medicine.
MCN Quarterly speaks with Australias leading national advocacy body for patients living with pain, Painaustralia, about the benefits and drawbacks of cannabis in the treatment of chronic pain.
Can you tell me a …

Click here to view the original article.